Keith S. Manchester, Director at Roivant Sciences Ltd. (ROIV), sold 9,041,208 shares at $4.75 ($37.3M) on 2022-11-10, disclosed to the SEC on 2022-11-14.
Open-market sale of $37.3M ROIV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,196,200 | $0 | 0.0% |
| 2 | $4.75 | 146,079 | $694K | 1.9% |
| 3 | $4.75 | 146,079 | $694K | 1.9% |
| 4 | $4.75 | 372,427 | $1.8M | 4.7% |
| 5 | $4.75 | 372,427 | $1.8M | 4.7% |
| 6 | $4.75 | 1,092,355 |
| $5.2M |
| 13.9% |
| 7 | $4.75 | 1,092,355 | $5.2M | 13.9% |
| 8 | $4.75 | 2,311,643 | $11.0M | 29.5% |
| 9 | $4.75 | 2,311,643 | $11.0M | 29.5% |
| Total | $4.12 avg | 9,041,208 | $37.3M | 100% |
| Filing → |
| ROIV | SELL | 2025-12-18 | $71.8M | — | Filing → |
| ROIV | SELL | 2025-11-21 | $29.8M | — | Filing → |
| ROIV | SELL | 2024-09-26 | $11.7M | — | Filing → |